Gilead Sciences(GILD.US)

Last Updated 19:00:00 ET
longbridge loading

Daiwa Securities Group Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

Market Beat·
US
GILD
+0.64%
US
XBI
-0.69%
US
IHE
+1.26%
Market Beat·
US
GILD
+0.64%
US
XBI
-0.69%
US
IHE
+1.26%

ProShare Advisors LLC Buys 623,752 Shares of Gilead Sciences, Inc. $GILD

Market Beat·
US
GILD
+0.64%
DE
GIS
0.00%
US
PBE
+0.11%
Market Beat·
US
GILD
+0.64%
DE
GIS
0.00%
US
PBE
+0.11%

Compugen Q1 Earnings Call Highlights

Market Beat·
US
GILD
+0.64%
US
CGEN
-4.55%
Market Beat·
US
GILD
+0.64%
US
CGEN
-4.55%

Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline

Market Beat·
DE
GIS
0.00%
US
GILD
+0.64%
US
SBIO
-1.24%
Market Beat·
DE
GIS
0.00%
US
GILD
+0.64%
US
SBIO
-1.24%

A Look At Gilead Sciences (GILD) Valuation After The Recent Share Price Pullback

Simplywall·
US
GILD
+0.64%
US
PBE
+0.11%
US
LABU
-2.35%
Simplywall·
US
GILD
+0.64%
US
PBE
+0.11%
US
LABU
-2.35%

Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

MarketWatch Automated·
US
GILD
+0.64%
US
XBI
-0.69%
US
BIB
+0.05%
MarketWatch Automated·
US
GILD
+0.64%
US
XBI
-0.69%
US
BIB
+0.05%

Gilead Sciences prices $3B multi-tranche senior notes offering

MSN·
US
GILD
+0.64%
MSN·
US
GILD
+0.64%

Gilead Prices $3 Billion of Senior Unsecured Notes | GILD Stock News

StockTitan·
US
GILD
+0.64%
US
BBH
+0.68%
US
XBI
-0.69%
StockTitan·
US
GILD
+0.64%
US
BBH
+0.68%
US
XBI
-0.69%
© 2026 Longbridge｜Disclaimer